adplus-dvertising
Connect with us

Business

AstraZeneca doses from U.S. will arrive in Canada next week, officials say – Global News

Published

 on


Canada expects to receive 1.5 million doses of the AstraZeneca vaccine next week through a sharing deal with the United States, officials confirmed Thursday.

“Public Services and Procurement Canada has recently negotiated the delivery of 1.5 million doses from the U.S., expected to arrive in Canada in the next week,” Maj.-Gen. Dany Fortin, the head of Canada’s COVID-19 vaccine distribution team, said at a news conference Thursday.

“When we have a confirmed delivery date to Canada, this quantity will be added to the quarterly distribution goal of vaccine doses.”

Canada has been in the midst of finalizing an agreement with its neighbour to the south that would see Ottawa receive 1.5 million doses of the AstraZeneca shot as a “loan.” In other words, Canada will eventually have to return the favour.

Read more:
Canada expects major surge in COVID-19 vaccine deliveries this week

Story continues below advertisement

Through a bilateral agreement, 20 million doses of AstraZeneca’s vaccine are expected to funnel into Canada from manufacturing plants in the U.S. over the second and third quarters of this year.

Joelle Paquette, director-general responsible for vaccine procurement at Public Services and Procurement Canada, said the 1.5 million slated to come to Canada next week will eventually be taken back by the U.S.

She said it will be subtracted by the U.S. from the 20-million bilateral agreement “for their own use.”

“We are still working with AstraZeneca and expect to have a delivery schedule for them in the coming week on the 20 million doses of our bilateral agreement,” she said.


Click to play video: '‘No indication’ India’s hold on AstraZeneca shots will impact Canada, officials say'



1:11
‘No indication’ India’s hold on AstraZeneca shots will impact Canada, officials say


‘No indication’ India’s hold on AstraZeneca shots will impact Canada, officials say

However, delivery schedules for the balance of the shots may remain murky.

Story continues below advertisement

On top of that, Health Canada is now reviewing two American manufacturing facilities that weren’t part of the agency’s initial authorization.

Health Canada’s chief medical adviser, Dr. Supriya Sharma, said Thursday that two facilities slated to manufacture AstraZeneca vaccines in the U.S. are currently under review “to make sure they meet the regulatory requirements” to produce the drug for Canadians.

Read more:
‘No indication’ India’s hold on AstraZeneca shots will impact Canada, officials say

In the interim, Health Canada will allow the vaccines from the yet-to-be-approved plants to come into Canada to be stored “so they will be in Canada for quick distribution” once they’re given the seal of approval to be administered.

“It’s just more making sure that those manufacturing facilities have the appropriate checks and balances in place to ensure the quality of the vaccine. So, good manufacturing process,” said Sharma.

“It’s not like a full vaccine authorization where we’re looking at clinical trials… It’s a much shorter process. We expect that to be completed in the coming days.”


Click to play video: 'Health Canada official comments on AstraZeneca COVID-19 vaccine concerns'



2:58
Health Canada official comments on AstraZeneca COVID-19 vaccine concerns


Health Canada official comments on AstraZeneca COVID-19 vaccine concerns

While a delivery schedule has not been established for AstraZeneca doses from the U.S., a shipment of about one million AstraZeneca doses made by the Serum Institute in India is expected to arrive sometime in April. The remaining 500,000 doses from that agreement will funnel into the country in May, for a total of two million from that deal.

Story continues below advertisement

As for the single-shot Johnson & Johnson vaccine, a delivery schedule has yet to materialize.

Fortin said discussions are “ongoing” and that Canada’s contracted 10 million doses are “expected by September,” though he provided no further detail.

By contrast, Canada’s other approved shots — Pfizer-BioNTech and Moderna — are coming into the country with increasing amounts and increasing clarity.


Click to play video: 'Canada on track to receive more than 12 million Pfizer COVID-19 vaccine doses between April and June'



2:04
Canada on track to receive more than 12 million Pfizer COVID-19 vaccine doses between April and June


Canada on track to receive more than 12 million Pfizer COVID-19 vaccine doses between April and June – Mar 18, 2021

Next week alone, Canada is expecting a shipment of 1.2 million doses from Pfizer. From there, the company plans to ship approximately one million doses every week from April to June.

Moderna is now shipping its shots every two weeks instead of three. Its next shipment is expected to arrive the first week of April and should include 855,000 doses. The following shipment, two weeks later, will jump to 1.2 million doses.

Story continues below advertisement

This week, Canada’s vaccine rollout hit a double-digit milestone, as 11 per cent of the country’s adult population has now received at least one dose of a COVID-19 shot.

Canada’s deputy chief public health officer, Dr. Howard Njoo, acknowledged the milestone, but said 11 per cent isn’t enough to stop the spread of the virus, especially as more transmissible and possibly more deadly versions of the virus continue to pose a “significant threat.”

— with files from The Canadian Press

© 2021 Global News, a division of Corus Entertainment Inc.

Let’s block ads! (Why?)

728x90x4

Source link

Continue Reading

Business

Roots sees room for expansion in activewear, reports $5.2M Q2 loss and sales drop

Published

 on

 

TORONTO – Roots Corp. may have built its brand on all things comfy and cosy, but its CEO says activewear is now “really becoming a core part” of the brand.

The category, which at Roots spans leggings, tracksuits, sports bras and bike shorts, has seen such sustained double-digit growth that Meghan Roach plans to make it a key part of the business’ future.

“It’s an area … you will see us continue to expand upon,” she told analysts on a Friday call.

The Toronto-based retailer’s push into activewear has taken shape over many years and included several turns as the official designer and supplier of Team Canada’s Olympic uniform.

But consumers have had plenty of choice when it comes to workout gear and other apparel suited to their sporting needs. On top of the slew of athletic brands like Nike and Adidas, shoppers have also gravitated toward Lululemon Athletica Inc., Alo and Vuori, ramping up competition in the activewear category.

Roach feels Roots’ toehold in the category stems from the fit, feel and following its merchandise has cultivated.

“Our product really resonates with (shoppers) because you can wear it through multiple different use cases and occasions,” she said.

“We’ve been seeing customers come back again and again for some of these core products in our activewear collection.”

Her remarks came the same day as Roots revealed it lost $5.2 million in its latest quarter compared with a loss of $5.3 million in the same quarter last year.

The company said the second-quarter loss amounted to 13 cents per diluted share for the quarter ended Aug. 3, the same as a year earlier.

In presenting the results, Roach reminded analysts that the first half of the year is usually “seasonally small,” representing just 30 per cent of the company’s annual sales.

Sales for the second quarter totalled $47.7 million, down from $49.4 million in the same quarter last year.

The move lower came as direct-to-consumer sales amounted to $36.4 million, down from $37.1 million a year earlier, as comparable sales edged down 0.2 per cent.

The numbers reflect the fact that Roots continued to grapple with inventory challenges in the company’s Cooper fleece line that first cropped up in its previous quarter.

Roots recently began to use artificial intelligence to assist with daily inventory replenishments and said more tools helping with allocation will go live in the next quarter.

Beyond that time period, the company intends to keep exploring AI and renovate more of its stores.

It will also re-evaluate its design ranks.

Roots announced Friday that chief product officer Karuna Scheinfeld has stepped down.

Rather than fill the role, the company plans to hire senior level design talent with international experience in the outdoor and activewear sectors who will take on tasks previously done by the chief product officer.

This report by The Canadian Press was first published Sept. 13, 2024.

Companies in this story: (TSX:ROOT)

The Canadian Press. All rights reserved.

Source link

Continue Reading

Business

Talks on today over HandyDART strike affecting vulnerable people in Metro Vancouver

Published

 on

 

VANCOUVER – Mediated talks between the union representing HandyDART workers in Metro Vancouver and its employer, Transdev, are set to resume today as a strike that has stopped most services drags into a second week.

No timeline has been set for the length of the negotiations, but Joe McCann, president of the Amalgamated Transit Union Local 1724, says they are willing to stay there as long as it takes, even if talks drag on all night.

About 600 employees of the door-to-door transit service for people unable to navigate the conventional transit system have been on strike since last Tuesday, pausing service for all but essential medical trips.

Hundreds of drivers rallied outside TransLink’s head office earlier this week, calling for the transportation provider to intervene in the dispute with Transdev, which was contracted to oversee HandyDART service.

Transdev said earlier this week that it will provide a reply to the union’s latest proposal on Thursday.

A statement from the company said it “strongly believes” that their employees deserve fair wages, and that a fair contract “must balance the needs of their employees, clients and taxpayers.”

This report by The Canadian Press was first published Sept. 12, 2024.

The Canadian Press. All rights reserved.

Source link

Continue Reading

Business

Transat AT reports $39.9M Q3 loss compared with $57.3M profit a year earlier

Published

 on

 

MONTREAL – Travel company Transat AT Inc. reported a loss in its latest quarter compared with a profit a year earlier as its revenue edged lower.

The parent company of Air Transat says it lost $39.9 million or $1.03 per diluted share in its quarter ended July 31.

The result compared with a profit of $57.3 million or $1.49 per diluted share a year earlier.

Revenue in what was the company’s third quarter totalled $736.2 million, down from $746.3 million in the same quarter last year.

On an adjusted basis, Transat says it lost $1.10 per share in its latest quarter compared with an adjusted profit of $1.10 per share a year earlier.

Transat chief executive Annick Guérard says demand for leisure travel remains healthy, as evidenced by higher traffic, but consumers are increasingly price conscious given the current economic uncertainty.

This report by The Canadian Press was first published Sept. 12, 2024.

Companies in this story: (TSX:TRZ)

The Canadian Press. All rights reserved.

Source link

Continue Reading

Trending